|
|
Article: Synexus 's new Phase IV clinical trial model increases number of doctors involved whilst cutting costs and time.
- Article from:
- M2 Presswire
- Article date:
- May 15, 2008
CopyrightCOPYRIGHT 2008 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-15 May 2008-Synexus: Synexus 's new Phase IV clinical trial model increases number of doctors involved whilst cutting costs and time(C)1994-2008 M2 COMMUNICATIONS LTD
RDATE:15052008
Manchester, England -- Synexus - the world's largest multi-national company specialising in the recruitment and running of late-stage clinical trials - is extending the scope of its studies to include Phase IV trials following the recent running of successful Phase IV studies for major pharmaceutical companies.
Phase IV trials (Post Marketing Surveillance Trials) allow pharma to monitor the wider use of a new medicine with both patients and doctors ...